Is there a way of safeguarding the supply of medicines in the case of a ‘no deal’ Brexit?

Is there a way of safeguarding the supply of medicines in the case of a ‘no deal’ Brexit?

By Dr. Jonathan Trethowan, Vice President Regulatory and Scientific Policy at PharmaLex Every month, there are 45 million patient packs of medicines transported from the UK to the EU, and 37 million patient packs transported from the EU to the UK. These products are moved in complex supply chains, but in the case of a […]